Replimune (REPL) Prepaid Assets (2018 - 2025)
Replimune's (REPL) quarterly Prepaid Assets came in at $8.3 million in Q4 2025, up 3.64% year-on-year from $8.0 million in Q4 2024, and little changed quarter-over-quarter from $8.3 million in Q3 2025.
Replimune (REPL) Prepaid Assets (2018 - 2025) Analysis & Trends
Replimune has disclosed Prepaid Assets across 8 years of filings, most recently posting $8.3 million for Q4 2025.
- Prepaid Assets for Q4 2025 came in at $8.3 million, up 3.64% year-over-year; the trailing twelve-month figure through Dec 2025 was $8.3 million (up 3.64% YoY), and the FY2025 annual result was $8.4 million, up 3.39% from the prior year.
- Prepaid Assets came in at $8.3 million for Q4 2025 at Replimune, roughly flat from $8.3 million in the prior quarter.
- In the past five years, Prepaid Assets ranged from a high of $8.5 million in Q3 2024 to a low of $3.3 million in Q2 2021.
- The 5-year median for Prepaid Assets is $7.1 million (2023), against an average of $6.7 million.
- Across the five-year window, Prepaid Assets surged 95.42% in 2023 and retreated 20.67% in 2024, its largest moves.
- Replimune's Prepaid Assets stood at $5.4 million in 2021, then climbed by 3.29% to $5.6 million in 2022, then soared by 52.35% to $8.5 million in 2023, then fell by 6.41% to $8.0 million in 2024, then rose by 3.64% to $8.3 million in 2025.
- The last three Prepaid Assets figures came in at $8.3 million (Q4 2025), $8.3 million (Q3 2025), and $8.2 million (Q2 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 762,369.55 Bn | 762,369.51 Bn | - |
| 2 | Belite Bio | 55,096.00 Bn | 55,096.00 Bn | - |
| 3 | Quantum Biopharma | 17,755.80 Bn | 17,755.79 Bn | - |
| 4 | Legend Biotech | 3,486.00 Bn | 3,485.71 Bn | 242.10 Mn |
| 5 | Akari Therapeutics | 1,737.42 Bn | 1,737.41 Bn | - |
| 6 | Evaxion A | 1,551.28 Bn | 1,551.26 Bn | - |
| 7 | Psyence Biomedical | 227.32 Bn | 227.31 Bn | - |
| 8 | Vertex Pharmaceuticals | 110.84 Bn | 103.59 Bn | 2.59 Bn |
| 9 | Abivax | 91.71 Bn | 91.71 Bn | - |
| 10 | Replimune | 780.01 Mn | 510.88 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 8.26 Mn |
| Sep 30, 2025 | 8.30 Mn |
| Jun 30, 2025 | 8.19 Mn |
| Mar 31, 2025 | 8.35 Mn |
| Dec 31, 2024 | 7.97 Mn |
| Sep 30, 2024 | 8.53 Mn |
| Jun 30, 2024 | 6.26 Mn |
| Mar 31, 2024 | 8.08 Mn |
| Dec 31, 2023 | 8.52 Mn |
| Sep 30, 2023 | 8.51 Mn |
| Jun 30, 2023 | 7.90 Mn |
| Mar 31, 2023 | 6.28 Mn |
| Dec 31, 2022 | 5.59 Mn |
| Sep 30, 2022 | 4.98 Mn |
| Jun 30, 2022 | 4.04 Mn |
| Mar 31, 2022 | 5.27 Mn |
| Dec 31, 2021 | 5.41 Mn |
| Sep 30, 2021 | 5.73 Mn |
| Jun 30, 2021 | 3.26 Mn |
| Mar 31, 2021 | 4.49 Mn |